Sierra Eye Associates

Az itteni vizsgálatok

Miről szól a helyszín 54 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Időskori makuladegeneráció38 vizsgálat
• Diabéteszes retinopátia17 vizsgálat

Fázis

• 2. fázis21 vizsgálat
• 3. fázis15 vizsgálat
• 1/2. fázis5 vizsgálat
• 1. fázis4 vizsgálat
• 4. fázis2 vizsgálat
• 2/3. fázis1 vizsgálat

Állapot

• Fut, nem toboroz18 vizsgálat
• Lezárult18 vizsgálat
• Toboroz9 vizsgálat
• Leállították4 vizsgálat
• Meghívásos bevonás3 vizsgálat
• Még nem toboroz2 vizsgálat

Fő szponzor

• Hoffmann-La Roche7 vizsgálat
• AbbVie5 vizsgálat
• Genentech, Inc.5 vizsgálat
• Gyroscope Therapeutics Limited5 vizsgálat
• 4D Molecular Therapeutics4 vizsgálat
• és még 20

Futó vizsgálatok

• Toboroz

  A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  NCT07029945· 1/2. fázis· Biojiva LLC· Forrás

  Contact: Clinical Research Coordinator

• Toboroz

  A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

  NCT07867080· 3. fázis· 4D Molecular Therapeutics· Forrás

  Contact: 4DMT Patient Advocacy

• Fut, nem toboroz

  COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449936· 3. fázis· EyePoint Pharmaceuticals, Inc.· Forrás

• Toboroz

  An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

  NCT07392255· 1/2. fázis· Complement Therapeutics· Forrás

  Contact: Muhammad Ali Memon

• Toboroz

  Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  NCT06659445· 2. fázis· ONL Therapeutics· Forrás

  Contact: Study Coordinator

• Toboroz

  A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  NCT07144137· Complement Therapeutics· Forrás

  Contact: Muhammad Ali Memon

• Toboroz

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· 3. fázis· 4D Molecular Therapeutics· Forrás

  Contact: 4DMT Patient Advocacy

• Toboroz

  A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  NCT06962839· 2. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  NCT06662162· i-Lumen Scientific AUS PTY LTD· Forrás

  Contact: Mandi Research Coordinator

• Toboroz

  Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)

  NCT06942520· 2. fázis· Sierra Eye Associates· Forrás

  Contact: Clinical Research Study Coordinator

• Fut, nem toboroz

  4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT06864988· 3. fázis· 4D Molecular Therapeutics· Forrás

• Fut, nem toboroz

  A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

  NCT06779773· Astellas Pharma Global Development, Inc.· Forrás

• Fut, nem toboroz

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  NCT06495918· 3. fázis· Ocular Therapeutix, Inc.· Forrás

• Fut, nem toboroz

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

  NCT06668064· 3. fázis· EyePoint Pharmaceuticals, Inc.· Forrás

• Toboroz

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)

  NCT06817343· 1. fázis· Exegenesis Bio· Forrás

• Fut, nem toboroz

  A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

  NCT06510816· 3. fázis· Annexon, Inc.· Forrás

• Fut, nem toboroz

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

  NCT06223958· 3. fázis· Ocular Therapeutix, Inc.· Forrás

• Fut, nem toboroz

  Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

  NCT06116916· 2. fázis· Kyowa Kirin Co., Ltd.· Forrás

• Toboroz

  A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

  NCT05626114· 2. fázis· Genentech, Inc.· Forrás

• Fut, nem toboroz

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

  NCT06847854· 1. fázis· Genentech, Inc.· Forrás

• Meghívásos bevonás

  ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

  NCT05481827· 2. fázis· Gyroscope Therapeutics Limited· Forrás

• Fut, nem toboroz

  An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

  NCT05300724· Genentech, Inc.· Forrás

• Fut, nem toboroz

  Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic Retinopathy

  NCT05296447· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema

  NCT05224102· 4. fázis· Genentech, Inc.· Forrás

• Meghívásos bevonás

  Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

  NCT05210803· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

  NCT04853251· 4. fázis· Genentech, Inc.· Forrás

• Toboroz

  4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  NCT05197270· 1/2. fázis· 4D Molecular Therapeutics· Forrás

  Contact: Huma Khan

• Fut, nem toboroz

  RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

  NCT04567550· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

  NCT04108156· 3. fázis· Hoffmann-La Roche· Forrás

• Meghívásos bevonás

  Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

  NCT03999801· 2. fázis· AbbVie· Forrás

• Toboroz

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  NCT03683251· 3. fázis· Hoffmann-La Roche· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Időskori makuladegeneráció11 toboroz
• Diabéteszes retinopátia3 toboroz

Lezárt vizsgálatok

• Lezárult

  A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

  NCT06172257· 3. fázis· Oculis· Forrás

• Lezárult

  Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

  NCT06116890· 2. fázis· Kyowa Kirin Co., Ltd.· Forrás

• Lezárult

  Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

  NCT06011798· 2. fázis· Unity Biotechnology, Inc.· Forrás

• Lezárult

  Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

  NCT05697809· 2. fázis· Oxular Limited· Forrás

• Lezárult

  A Study of EXG102-031 in Patients With wAMD (Everest)

  NCT05903794· 1. fázis· Exegenesis Bio· Forrás

• Lezárult

  Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

  NCT05891548· 2. fázis· Clearside Biomedical, Inc.· Forrás

• Lezárult

  A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

  NCT05839041· 2. fázis· Aviceda Therapeutics, Inc.· Forrás

• Lezárult

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

  NCT05797896· Complement Therapeutics· Forrás

• Lezárult

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Lezárult

  A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

  NCT05151731· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· 3. fázis· Apellis Pharmaceuticals, Inc.· Forrás

• Lezárult

  RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

  NCT04832724· 2. fázis· AbbVie· Forrás

• Lezárult

  Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

  NCT04567303· 1/2. fázis· Hoffmann-La Roche· Forrás

• Leállították

  HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04566445· 2. fázis· Gyroscope Therapeutics Limited· Forrás

• Lezárult

  A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm

  NCT04503551· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· 2. fázis· Oxurion· Forrás

• Lezárult

  A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema

  NCT06771271· 1. fázis· Hoffmann-La Roche· Forrás

• Leállították

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· 2. fázis· Gyroscope Therapeutics Limited· Forrás

• Leállították

  GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

  NCT03894020· Gyroscope Therapeutics Limited· Forrás

• Leállították

  FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

  NCT03846193· 1/2. fázis· Gyroscope Therapeutics Limited· Forrás